yannan yang - Nanotechnology

Author Information

Yannan Yang is affiliated with the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland, Brisbane, QLD 4072, Australia. Yang's research primarily focuses on nanotechnology and its applications in cancer treatment, immunotherapy, and antibacterial coatings.

Research Contributions

Yannan Yang has made significant contributions in the field of nanotechnology, particularly in developing novel nanomaterials for cancer treatment and immunotherapy. Some of the key research includes the synthesis of MnFe2O4-dichloroacetic acid nanocomposites for reversing tumor immunosuppressive microenvironments, designing antibacterial silica nanoparticles, and creating immune-regulating bimetallic metal-organic framework nanoparticles. Additionally, Yang's work also encompasses the development of quantum dots for immunoassays and investigating the role of nanotechnology in reactive species regulation within biosystems.

Aliases

There are no aliases available for Yannan Yang.

Publication and Citation Metrics

Metric	Value
Citation Count	3876
h-index	32
Paper Count	101

Publications:

A Sub-6 nm MnFe2O4-dichloroacetic acid nanocomposite modulates tumor metabolism and catabolism for reversing tumor immunosuppressive microenvironment and boosting immunotherapy.

DOI: 10.1016/j.biomaterials.2022.121533

Year: 2022

In-situ Synthesis of Drug-Containing Bactericidal Rough Silica Nanoparticles for Antibacterial Coating

DOI: 10.1016/j.cej.2022.135837

Year: 2022

Surfactant-free synthesis of monodispersed organosilica particles with pure sulfide-bridged silsesquioxane framework chemistry via extension of Stöber method.

DOI: 10.1016/j.jcis.2021.01.071

Year: 2021

Designer Anticancer Nanoprodrugs with Self‐Toxification Activity Realized by Acid‐triggered Biodegradation and In Situ Fragment Complexation

DOI: 10.1002/ange.202102704

Year: 2021

Quantum dots’ size matters for balancing their quantity and quality in label materials to improve lateral flow immunoassay performance for C-Reactive protein determination

DOI: 10.1016/j.bios.2021.113892

Year: 2021

Designer Anticancer Nanoprodrugs Featuring Self-toxification Activity Realized by Acid-triggered Biodegradation and in situ Fragments Complexation.

DOI: 10.1002/anie.202102704

Year: 2021

Immune-regulating bimetallic metal-organic framework nanoparticles designed for cancer immunotherapy.

DOI: 10.1016/j.biomaterials.2021.121261

Year: 2021

Ferroptosis-Strengthened Metabolic and Inflammatory Regulation of Tumor-Associated Macrophages Provokes Potent Tumoricidal Activities.

DOI: 10.1021/acs.nanolett.1c01401

Year: 2021

Nanotechnology enabled reactive species regulation in biosystems for boosting cancer immunotherapy

DOI: 10.1016/j.nantod.2020.101035

Year: 2021

MnO2 Nanoflowers Induce Immunogenic Cell Death under Nutrient Deprivation: Enabling an Orchestrated Cancer Starvation‐Immunotherapy

DOI: 10.1002/advs.202002667

Year: 2021

Why is CSR Important in Nanotechnology?

How do Nanostructured Materials improve Absorbers?

How Do Polishing Machines Work?

What is the Role of Collaboration in NCL?

What are the Advantages of Using Synchrotron Sources?

How is Nanotechnology Regulated?

What are the Limitations of Quantum Espresso?

What are the Core Areas of Focus?

What Role Does Nanotechnology Play in Environmental Monitoring?

How is Enhanced Electrostatic Control Achieved?

Partnered Content Networks

Relevant Topics